Psychophysiological Evaluation of Short-term Neurotoxicity After Prophylactic Brain Irradiation in Patients with Small Cell Lung Cancer: a Study of Event Related Potentials
Overview
Authors
Affiliations
Background: The aim of this study was to show, whether a certain prophylacting applicable radiation affects the cognition, particularly, the specific cognitive components P50, N100, P300 and N400 of auditory event related potentials (ERPs) during a short memory test.
Methods And Materials: Eleven patients with small cell lung cancer (SCLC), who had presented complete response of disease after chemotherapy and radical radiotherapy in the lung, were prescribed to receive a prophylacting cranial irradiation (PCI) with a 6 MeV linear accelerator. The dose schedule was consisting of a total dose up to 30 Gy in 10 fractions, within 12 days (5 days a week). The psychophysiological approach before and after PCI was assessed by measurements of the auditory ERPs during a short memory performance using the digit-span Wechsler test. Components of ERP were recorded from 15 scalp electrodes. Additionally, symptomatology of depression and anxiety were assessed using Zung Self-Rating Depression Scale and Spielberger Anxiety Inventory, respectively, for pre- and post-PCI.
Results: No significant difference was noticed pre- and post-radiotherapy of all particular level of psychophysiological analysis concerning both the latencies and the amplitudes of ERPs auditory components P50, N100, P300 and N400 (P > 0.05, Wilcoxon signed test). Additionally, no changes were found with regard to behavioral performance (memory recall), depression symptomatology and state anxiety, according to pre- and post-radiation measurements. However, the self-reported depression symptomatology showed that the patients presented moderate depression.
Conclusion: No short-term psychophysiological neurotoxicity was detected with this PCI schedule using these instruments, lending additional support to evidence suggesting the benefit of this certain PCI schedule for patients with SCLC.
A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice.
Gandal M, Ehrlichman R, Rudnick N, Siegel S Neuroscience. 2008; 157(1):95-104.
PMID: 18835334 PMC: 2715916. DOI: 10.1016/j.neuroscience.2008.08.060.
Jatoi A, Kahanic S, Frytak S, Schaefer P, Foote R, Sloan J Support Care Cancer. 2004; 13(1):66-9.
PMID: 15480814 DOI: 10.1007/s00520-004-0696-0.